Full Text View
Tabular View
No Study Results Posted
Related Studies
Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome (BTX-URO-01)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Cantonal Hospital of St. Gallen.
Recruitment status was  Recruiting
Study NCT00464373   Information provided by Cantonal Hospital of St. Gallen

First Received on April 20, 2007.   Last Updated on February 10, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostatitis
Additional conditions recognized in this trial
Chronic Disease
Pelvic Pain
Somatoform Disorders
More general conditions related to this trial
Disease Attributes
Genital Diseases, Male
Mental Disorders
Pain
Pathologic Processes
Prostatic Diseases
Signs and Symptoms
Interventions listed in this trial
Botulinum Toxin Type A
Placebo
Additional drug interventions recognized in this trial
Botulinum Toxins
Botulinum Toxins, Type A
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cantonal Hospital of St. Gallen
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services